Cytek Biosciences, Inc. — Director's Dealing 2021

Jul 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytek Biosciences, Inc. (CTKB)
CIK: 0001831915
Period of Report: 2021-07-22

Reporting Person: Ball Jack (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-22	Common Stock	P	3000	$17.00	Acquired	3000	Direct

Footnotes

F1: Reflects shares purchased from the underwriters in the Company's initial public offering.